Trial intelligence / Profile preview

Tailored Rescue Therapy for H. pylori

NCT03413020Phase 4Completed

Sponsor
Shanghai Jiao Tong University School of Medicine
Start
Jan 2018
Primary completion
Jul 2018
Modality
DNA Intercalators/Alkylators
Countries
1
01

Overview

A Phase 4 trial of esomeprazole, amoxicillin, clarithromycin, metronidazole, levofloxacin in Helicobacter pylori infection, sponsored by Shanghai Jiao Tong University School of Medicine. Started Jan 2018; status: completed.

02

Drugs

esomeprazoleamoxicillinclarithromycinmetronidazolelevofloxacin
03

Conditions

Helicobacter pylori infection

Beyond the preview

Go deeper on NCT03413020.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03413020.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call